Biotech | April 20, 2026
Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Paves the way for next-gen ultra-precise gas sensing
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
Its a major breakthrough for women’s ovarian cancer care in Europe
The FDA approval makes PD-L1 IHC 22C3 pharmDx the only companion diagnostic approved to detect tumors expressing PD-L1 in esophageal or GEJ carcinoma patients for KEYTRUDA treatmen
The Trust’s shift from single-use compostable cups to a reusable system was driven by the need to reduce environmental impact and control long-term costs
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
Subscribe To Our Newsletter & Stay Updated
